Skip to content
Mesa PRP Label Guide
Medical claims, translated one verb at a time

Mesa PRP Label Guide

Who may consider PRP and who needs prompt care

This page tells you which symptoms can wait, which ones need prompt care, and what soreness may follow PRP. We'll keep the two situations separate. Your safety comes first.

Fever, a hard fall, or sudden weakness needs prompt care

Joint soreness that lingers can usually wait for a regular appointment. Fever with a swollen, hot joint can't wait. A sudden pop followed by lost strength also needs prompt care, as does a leg that suddenly won't hold you.

Please seek help after a hard fall if the joint looks bent. New weakness or loss of bladder control with back pain is urgent too. These symptoms need medical care before any talk about PRP, and you can return to that question later.

PRP may cause soreness and swelling for several days

Here PRP means platelet-rich plasma, a shot prepared after your blood is drawn. A machine spins the blood and separates fluid with many platelets for the syringe. Platelets are blood cells that clump after a cut and help the body begin repair, and the clinician puts that fluid into the sore joint or tendon during the visit.

More soreness or swelling can last for several days after the shot. The clinic can tell you what isn't normal. Rising pain, spreading redness, pus, fever, or feeling ill needs urgent care, so please don't ignore a worsening symptom.

Blood thinners, bleeding trouble, and an active infection need review before a procedure. Tell the clinician about the medicines you take. Don't stop a medicine yourself, because the doctor who manages it can guide you.

A careful visit may lead to another kind of care

When soreness continues, QC Kinetix has orthobiologics among its choices. The word means joint or tendon care prepared at the clinic with material taken from your blood, such as PRP. Medical providers are the clinicians who examine you and check your health, and they may advise different care first.

Old X-rays and medicine names may help during your appointment. Tell the clinician how sleep, walking, or work has changed. The visit shouldn't hurry you, and a different answer may be the safer one.

Sources

  1. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

    Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.

  2. The American Academy of Physical Medicine and Rehabilitation convened a technical expert panel that ran a structured literature review (2023, updated through June 2025) and a modified Delphi process, and issued five evidence-based clinical recommendations plus 11 consensus-based best practices for PRP in knee osteoarthritis. The statement is explicit that orthobiologic therapies 'remain an evolving area of practice' and that robust, dose-dependent randomized controlled trials are still needed to establish PRP's clinical effects.

    Borg-Stein J, Jayaram P, Colorado BS, et al. — AAPM&R guidance statement on platelet rich plasma for knee osteoarthritis. PM&R, 2026. DOI: 10.1002/pmrj.70144.

  3. The 2019 ACR/Arthritis Foundation osteoarthritis guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-management programmes, tai chi, cane use, tibiofemoral bracing, topical and oral NSAIDs and intra-articular glucocorticoid injections for knee OA. Its conditional recommendations cover balance exercises, yoga, CBT, acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol. Anything offered before a course of the strongly recommended options is being offered out of order.

    Kolasinski SL, Neogi T, Hochberg MC, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

  4. A Bayesian network meta-analysis of nine studies (six RCTs, 1055 patients) found leukocyte-POOR PRP produced significantly better WOMAC scores than hyaluronic acid (mean difference -21.14; 95% CI -39.63 to -2.65) and than placebo (-17.84; 95% CI -34.95 to -0.73), while leukocyte-RICH PRP showed no such significant difference versus placebo. PRP of either type caused more local adverse reactions than hyaluronic acid (OR 5.63; 95% CI 1.38-22.90), almost always local swelling and pain, with no difference in safety between the two PRP types.

    Riboh JC, Saltzman BM, Yanke AB, et al. — Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis. American Journal of Sports Medicine, 2016. DOI: 10.1177/0363546515580787.

  5. The Cochrane review of STEM CELL injections for knee osteoarthritis concluded that on low-certainty evidence they may slightly improve pain and function, with uncertainty about effects on quality of life, treatment success and structural progression, and uncertainty about safety. This matters on a PRP site because 'stem cell therapy' is routinely used as a marketing label for PRP; they are different products with different evidence and PRP must never be described as a stem cell treatment.

    Whittle SL, Johnston RV, McDonald S, et al. — Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2025. DOI: 10.1002/14651858.CD013342.pub2.

  6. In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.

    Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

A clinic can examine soreness that keeps returning

When the ache hasn't settled, QC Kinetix has regenerative treatment options. In plain words, this is non-surgical care made at the clinic with material drawn from your blood. One choice is PRP, or platelet-rich plasma, prepared by spinning the blood and saving fluid with many platelets. Those cells help a cut clot and send repair signals.

The clinicians serving as medical providers examine you and consider your health and earlier care first. Most Mesa readers use Chandler. North and northeast Mesa may find Scottsdale easier, and you can call (602) 837-PAIN when you're ready to talk.

Book a free consultation